Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 48Congress 0Executive branch 0Insiders 48
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

PBLS · buys only · $50K+ · 48 trades

Trades
48
Buys 48 · Sells 0
People
14
Stocks
1
Disclosed value
$125M
range midpoints · Congress & executive
Filed late
18
  1. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$190Kdisclosed Jul 22 · filed 1 day after the trade
  2. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$607Kdisclosed Jul 22 · filed 1 day after the trade
  3. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  4. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$607Kdisclosed Jul 22 · filed 1 day after the trade
  5. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$607Kdisclosed Jul 22 · filed 1 day after the trade
  6. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  7. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$914Kdisclosed Jul 22 · filed 2 days after the trade
  8. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$914Kdisclosed Jul 22 · filed 2 days after the trade
  9. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  10. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$914Kdisclosed Jul 22 · filed 2 days after the trade
  11. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  12. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$914Kdisclosed Jul 22 · filed 2 days after the trade
  13. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$607Kdisclosed Jul 22 · filed 1 day after the trade
  14. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  15. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  16. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  17. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  18. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  19. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$1.1Mdisclosed Jul 22 · filed 1 day after the trade
  20. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$190Kdisclosed Jul 22 · filed 1 day after the trade
  21. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$190Kdisclosed Jul 22 · filed 1 day after the trade
  22. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  23. ▲ BUYRA Capital Healthcare Fund LP DirectorPBLS Parabilis Medicines, Inc.$2.7Mdisclosed Jul 22 · filed 2 days after the trade
  24. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  25. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$190Kdisclosed Jul 22 · filed 1 day after the trade